Ghent-based healthcare startup IntelliProve has raised €1.25 million in seed funding to advance its contactless optical technology for instant health measurement.
- Established in 2021 by Joeri Tulkens, Tanguy Sanglet, Brecht Dhuyvetters, and Maxime Mattelin, IntelliProve develops software that uses optical facial measurements to determine physiological and mental health parameters.
- The technology captures a 20-second video of a user's face, applies AI and signal processing to analyze blood flow and other vital indicators, and provides real-time, clinically validated biomarker data for integration into healthcare platforms and applications.
"We’re on a mission to revolutionize health monitoring through optical face analysis! From building a deeptech innovation to scaling internationally," co-founder and CEO of IntelliProve, Joeri Tulkens, stated.
- The startup serves clients including BloomUp, OptimallyMe, Health Blocks, Helan, and Neutraal Ziekenfonds Vlaanderen, and operates in Belgium, the Netherlands, the United Kingdom, Italy, France, Germany, and Denmark.
Details of the deal
- The seed funding saw support from Ghent-based VC Miles Ahead, and several business angels.
"Miles Ahead empowers impactful start-ups that leverage technology to drive positive change. IntelliProve has the potential to revolutionize healthcare and make it accessible for everyone. They stand out with their strong and passionate team and innovative approach to preventive healthcare," Miles Ahead's team, commented on LinkedIn.
- Existing investors, including Wit-Gele Kruis West-Vlaanderen, Wit-Gele Kruis van Antwerpen, and imec.istart also joined this round.
- IntelliProve will use the funds to refine its health assessment technology and expand across Europe, enhancing its accessibility and user experience.
- The investment will also support team growth and partnerships to accelerate adoption in digital health, corporate well-being, and health insurance sectors.
